CEO at Valisure

From Yale University
Greater New York City Area


Founded and funded Valisure in 2015 with a team of Yale entrepreneurs. Developed a novel analytical technology for the precision analysis of pharmaceuticals which received full ISO 17025 accreditation and 3 patent filings. Secured an unprecedented combination of FDA, DEA and state licenses and registrations to launch a truly novel and disruptive business model that combines both analytical laboratory and pharmacy. Spearheaded the rapid growth and financing of the company and put the major components in motion to launch the nation's first digital pharmacy that dispenses only chemically validated medications in 2018.
June 2015 - Present
(5 Years and 3 Months)


Angel Investor
Invest in early stage technology and novel business models with potential for disruptive impact. An active member of the Landmark Angels group but invest independently.
January 2015 - Present
(5 Years and 8 Months)

Family ReEntry

Member Board Of Directors
Assist with the corporate management and outreach of Family ReEntry and help in their mission to empower individuals and strengthen families impacted by the criminal justice system.
January 2017 - Present
(3 Years and 8 Months)

Thermo Fisher Scientific

Director Product Management
Manage product commercialization and life cycle for advanced technology development programs of Ion Torrent's semiconductor sequencing platform. Closely connect with R&D to provide insight and direction based on market and technical expertise. Successfully completed development and commercially launched Ion's flagship technology program. … see more
January 2014 - January 2017
(3 Years and 1 month)

Pallasite Ventures

Founder & Chairman
Manage small real estate investment firm specializing in New Haven properties. Sold business at 205% ROI.
January 2012 - January 2016
(4 Years and 1 month)

The Rothberg Institute

Sequencing Facility Director
Manage sequencing facility utilizing Ion Torrent technology with a focus on unique and broadly impacting sequencing projects.
January 2011 - January 2016
(5 Years and 1 month)

Life Technologies

Head of Chemistry R&D
Direct majority of chemistry related research at Ion Torrent and development leader for the Proton 2 system.
January 2013 - January 2014
(1 year and 1 month)

Ion Torrent by Life Technologies

Manager, Chemistry R&D
Lead R&D team to develop Ion Sphere technology for commercial launch. Invented new manufacturing processes enabling Ion Sphere improvements to increase sequencing output a further 4X. Facilitate the expansion of bead efforts at other Life sites and the development of the Proton program.
January 2010 - January 2013
(3 Years and 1 month)

Ion Torrent by Life Technologies

Research Associate
Establish proof of principle for Ion Torrent Technology. Co-inventor of "Ion Spheres" enabling 4X signal boost on Ion platform. Spear headed Ion Sphere development and leveraged small team to invent novel manufacturing processes and analytical methods.
January 2008 - January 2010
(2 Years and 1 month)

Synthetic Genomics

Molecular Biology Consultant
January 2007 - January 2008
(1 year and 1 month)

RainDance Technologies

Chairman Advisor, Market Research & Business Development
Not available

454 Life Sciences

Sales Associate & Analyst
Not available
Not available